Trevena Inc (NAS:TRVN)
$ 6.7 -0.79 (-10.55%) Market Cap: 5.71 Mil Enterprise Value: 26.50 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 23/100

Trevena Inc at JMP Securities Life Sciences Conference Transcript

Jun 15, 2022 / 02:00PM GMT
Release Date Price: $258.63 (+3.74%)
Jason Butler
JMP Securities LLC - Analyst

Thanks, everybody, again for joining us this morning at the JMP Securities Life Science Conference. Again, thank you to everybody for being here in person.

The next company we have presenting with us today or speaking with us today is Trevena. And we have Carrie Bourdow, the company's CEO; and Mark Demitrack, Chief Medical Officer. Thank you for being here.

Really been an exciting year with the OLINVYK launch and making progress there. And you have a pipeline, which I think is truly underappreciated and a lot to talk about there as well.

But before we jump in, why don't I just turn it over to you, Carrie, for a couple introductory statements and then we will jump in.

Carrie Bourdow
Trevena, Inc. - President & CEO

Great. Well, first off, Jason, thank you so much for inviting us, and we are very excited to be here live. There's been all kinds of jokes today about suits that we are wearing and real pants that we are wearing. So I'm thrilled to be here and see live faces in the audience.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot